Orgenesis Inc.
ORGS · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.01 | 1.62 | 0.46 | -0.06 |
| FCF Yield | -11.67% | -7.63% | -4.97% | -8.29% |
| EV / EBITDA | -2.75 | -61.82 | -44.88 | -9.84 |
| Quality | ||||
| ROIC | -3,180.09% | -9.58% | -33.23% | -142.66% |
| Gross Margin | -1,080.19% | 43.26% | 20.68% | -306.42% |
| Cash Conversion Ratio | 0.23 | 2.05 | 1.49 | -134.79 |
| Growth | ||||
| Revenue 3-Year CAGR | -75.38% | 67.60% | 2.20% | -25.70% |
| Free Cash Flow Growth | 54.65% | -7.51% | 56.35% | -213.90% |
| Safety | ||||
| Net Debt / EBITDA | -0.36 | -1.83 | -0.41 | 0.34 |
| Interest Coverage | -24.75 | -4.13 | -45.53 | -87.55 |
| Efficiency | ||||
| Inventory Turnover | 183.97 | 170.33 | 238.64 | 168.10 |
| Cash Conversion Cycle | 1,382.87 | 326.60 | 135.82 | 55.88 |